Eleview™ is an injectable composition patented by Cosmo.

The objective is to create a product that allows endoscopist a faster and less risky excision of adenomas or polyps discovered during endoscopy. The composition is injected between the mucosal layers where it clearly separates the mucosal layers for more than 60 minutes. The composition is stained with Methylene Blue thus allowing a clear differentiation of the tissues. This gives the endoscopist sufficient time to cut out the growths and greatly reduces the risks that the colon is perforated in the procedure.

The FDA approved the product in September 2015. In the EU the product was approved in June 2016.

Eleview will be marketed by Cosmo in the USA. In the Rest of the World licensing/ distribution partnerships are being sought. Go to Eleviewus.com >

Delivered by Investis – link to website (opens in a new window)